Artificial intelligence (AI) has the potential to make substantial progress toward the goal of
making healthcare more personalized, predictive, preventative, and interactive. We believe …

The idea of artificial intelligence (AI) has a long history. It turned out, however, that reaching
intelligence at human levels is more complicated than originally anticipated. Currently, we …

Imbalanced immune responses are a prominent hallmark of cancer and autoimmunity.
Myeloid cells can be overly suppressive, inhibiting protective immune responses or inactive …

Endocrine therapy is important for management of patients with estrogen receptor (ER)–
positive breast cancer; however, positive ER staining does not reliably predict therapy …

In the last decade, tremendous progress in curative treatment has been made for T-ALL
patients using high-intensive, risk-adapted multi-agent chemotherapy. Further treatment …

Aim Salivary duct carcinoma (SDC), an aggressive subtype of salivary gland cancer, is
androgen receptor (AR)–positive in 67–96% of cases. In patients with locally recurrent and …

Objective Salivary duct carcinoma (SDC) overexpresses Human Epidermal growth factor
Receptor 2 (HER2) in 29–46% of cases, favoring anti-HER2 therapy. Here, we present the …

Androgen deprivation therapy (ADT) is first‐line palliative treatment in androgen receptor‐
positive (AR+) salivary duct carcinoma (SDC), and response rates are 17.6–50.0%. We …

Patients with bladder cancer often have a poor prognosis due to the highly invasive and
metastatic characteristics of bladder cancer cells. Epithelial-to-mesenchymal transition …

Combined cellular and humoral host immune response determine the clinical course of a
viral infection and effectiveness of vaccination, but currently the cellular immune response …